These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30444129)

  • 1. Conditional estimation and inference to address observed covariate imbalance in randomized clinical trials.
    Zhang Z; Tang L; Liu C; Berger VW
    Clin Trials; 2019 Apr; 16(2):122-131. PubMed ID: 30444129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How large are the consequences of covariate imbalance in cluster randomized trials: a simulation study with a continuous outcome and a binary covariate at the cluster level.
    Moerbeek M; van Schie S
    BMC Med Res Methodol; 2016 Jul; 16():79. PubMed ID: 27401771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring continuous baseline covariate imbalances in clinical trial data.
    Ciolino JD; Martin RH; Zhao W; Hill MD; Jauch EC; Palesch YY
    Stat Methods Med Res; 2015 Apr; 24(2):255-72. PubMed ID: 21865270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of baseline covariate imbalance on bias in treatment effect estimation in cluster randomized trials: Race as an example.
    Yang S; Starks MA; Hernandez AF; Turner EL; Califf RM; O'Connor CM; Mentz RJ; Roy Choudhury K
    Contemp Clin Trials; 2020 Jan; 88():105775. PubMed ID: 31228563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
    Shimura M; Gosho M; Hirakawa A
    Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization.
    Ciolino J; Zhao W; Martin R; Palesch Y
    Contemp Clin Trials; 2011 Mar; 32(2):250-9. PubMed ID: 21078415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous covariate imbalance and conditional power for clinical trial interim analyses.
    Ciolino JD; Martin RH; Zhao W; Jauch EC; Hill MD; Palesch YY
    Contemp Clin Trials; 2014 May; 38(1):9-18. PubMed ID: 24607294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reacting to prognostic covariate imbalance in randomised controlled trials.
    Coskinas X; Schou IM; Simes J; Martin A
    Contemp Clin Trials; 2021 Nov; 110():106544. PubMed ID: 34454099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and implication of prognostic imbalance in randomized controlled trials with a binary outcome--a simulation study.
    Chu R; Walter SD; Guyatt G; Devereaux PJ; Walsh M; Thorlund K; Thabane L
    PLoS One; 2012; 7(5):e36677. PubMed ID: 22629322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive Randomization Method to Prevent Extreme Instances of Group Size and Covariate Imbalance in Stroke Trials.
    Italiano D; Campbell B; Hill MD; Johns HT; Churilov L
    Stroke; 2024 Aug; 55(8):1962-1972. PubMed ID: 38920051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covariate adjustment in subgroup analyses of randomized clinical trials: A propensity score approach.
    Yang S; Li F; Thomas LE; Li F
    Clin Trials; 2021 Oct; 18(5):570-581. PubMed ID: 34269087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doubly robust inference for targeted minimum loss-based estimation in randomized trials with missing outcome data.
    Díaz I; van der Laan MJ
    Stat Med; 2017 Oct; 36(24):3807-3819. PubMed ID: 28744883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Susceptibility of Marginal Odds Ratios to Finite-sample Bias.
    Ross RK; Cole SR; Richardson DB
    Epidemiology; 2021 Sep; 32(5):648-652. PubMed ID: 34001751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential covariate-adjusted randomization via hierarchically minimizing Mahalanobis distance and marginal imbalance.
    Yang H; Qin Y; Li Y; Hu F
    Biometrics; 2024 Mar; 80(2):. PubMed ID: 38801258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choosing an imbalance metric for covariate-constrained randomization in multiple-arm cluster-randomized trials.
    Ciolino JD; Diebold A; Jensen JK; Rouleau GW; Koloms KK; Tandon D
    Trials; 2019 May; 20(1):293. PubMed ID: 31138319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covariate adjustment and estimation of mean response in randomised trials.
    Bartlett JW
    Pharm Stat; 2018 Sep; 17(5):648-666. PubMed ID: 29998483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Simulation-Based Comparison of Covariate Adjustment Methods for the Analysis of Randomized Controlled Trials.
    Chaussé P; Liu J; Luta G
    Int J Environ Res Public Health; 2016 Apr; 13(4):414. PubMed ID: 27077870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive pair-matching in randomized trials with unbiased and efficient effect estimation.
    Balzer LB; Petersen ML; van der Laan MJ;
    Stat Med; 2015 Mar; 34(6):999-1011. PubMed ID: 25421503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of treatment effect under non-proportional hazards and conditionally independent censoring.
    Boyd AP; Kittelson JM; Gillen DL
    Stat Med; 2012 Dec; 31(28):3504-15. PubMed ID: 22763957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.